SCHEMBL6313909

SCHEMBL6313909

Cc1nc2c(nc1N1CCCC1)c(=O)n(C)c(=O)n2C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
KDM4E B2RXH2 3/20 0.53
LMNA P02545 3/20 0.53
HTT P42858 3/20 0.53
HPGD P15428 2/20 0.53
JAK2 O60674 1/20 0.53
PAX8 Q06710 1/20 0.53
KMT2A Q03164 4/20 0.50
MEN1 O00255 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.41
ADORA2A P29274 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401730 0.79 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL5448291 0.78 ALDH1A1 (0.73) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL6316327 0.77 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL26312966 0.74 ALDH1A1 (0.66) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL5449135 0.73 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL6314318 0.72 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL10524326 0.72 ALDH1A1 (0.63) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL12355771 0.70 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL5434690 0.69 ALDH1A1 (0.65) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL5448218 0.67 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 ALDH1A1 1744/4885KDM4E 1278/4885LMNA 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.